Sharp inks preferred partnership with CMO to reduce clinical trial complexity

By Melissa Fassbender contact

- Last updated on GMT

(Image: Gety/Anawat_s)
(Image: Gety/Anawat_s)

Related tags: CMO, Clinical trial management, Preferred partnership, Contract manufacturing

Sharp has signed a preferred partnerships agreement with an MA-based CMO to reduce “friction” for clients while decreasing the time, cost, and complexity of managing clinical trials.

Sharp – part of UDG Healthcare – provides contract packaging and clinical supply services. The company this week confirmed a preferred partner agreement with the fill/finish contract manufacturing organization (CRMO) Berkshire Sterile Manufacturing (BSM).

The agreement bolsters Sharp’s ability to provide sterile fill/finish clinical manufacturing services and gives BSM clients access to clinical trial supply and management services, including analytical testing, stability, clinical and commercial packaging, serialization, IRT services, QP services, storage as well as distribution.

Dan Gourley, senior director, Global Logistics for Sharp Clinical US, sad the companies wanted to address clients’ needs by providing sterile manufacturing through to delivery of clinical trial materials to sites. 

“This partnership simplifies our clients' supply chain in that they can work with one contracted provider for all of these activities,”​ he told us, adding that the companies have worked together in the past and have several current projects underway. 

The partnership agreement comes into effect immediately and is evergreen, Gourley said.

“Through this agreement, we are harmonizing how we work together and by having a single point of contact for our combined services, we reduce ‘friction’ for our clients,”​ he added.

As an example, Gourley explained that reciprocal vendor audits conducted by Sharp and BSM would negate the requirement for clients to conduct individual audits.

He added, “We aspire to reduce the time, cost and complexity of managing clinical trials and strategic partnerships like this are a vital element of working towards that goal.”

Related news

Show more

Related products

show more

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Formedix | 09-Jun-2021 | Technical / White Paper

This article explains the different types of clinical trial software available, and how it can be used to optimize the end to end clinical trials design...

Integrated Solutions for Accelerated Time to Market

Integrated Solutions for Accelerated Time to Market

Piramal Pharma Solutions | 08-Jun-2021 | Technical / White Paper

Facing capacity constraints? Lock in your program now! With 14 sites around the world providing diverse services ranging from discovery to drug substance...

Transforming Clinical Development

Transforming Clinical Development

PerkinElmer | 01-Jun-2021 | Technical / White Paper

The estimated cost of bringing a drug to market in the U.S. according to JAMA is $1 billion.1 The extreme cost of clinical trials urge biopharmaceutical,...

Adapting supply chains to new ways of working

Adapting supply chains to new ways of working

World Courier | 01-Jun-2021 | Technical / White Paper

COVID-19 has changed the way we operate. We have adapted our supply chain solutions to meet our clients’ requirements while following World Courier standard...

Related suppliers

Follow us

Products

View more

Webinars